Serum-insulin in essential hypertension and in peripheral vascular disease.
about
Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarctionHyperinsulinemia. A link between hypertension obesity and glucose intoleranceMetabolic syndrome as a risk factor for gallstone disease.Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic miceThe metabolic syndrome X.Insulin resistance and cardiovascular disease.Insulin resistance and risk of incident hypertension among men.Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertensionPrevalence and risk factors of chronic kidney disease in urban adult Cameroonians according to three common estimators of the glomerular filtration rate: a cross-sectional study.Insulin resistance and cardiovascular drugs.Fasting serum insulin levels in childhood.Insulin resistance, hyperinsulinemia, dyslipidemia, hypertension, and accelerated atherosclerosis.A closer look at the role of urotensin II in the metabolic syndrome.Insulin resistance and hypertension--implications for treatment.The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Insulin resistance and hyperinsulinemia: you can't have one without the other.Insulin resistance, hyperinsulinemia, and hypertension: an epidemiologic approach.Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndromeHypertension in diabetic patients--use of exercise in treatment.The effect of dietary sucrose on blood lipids, serum insulin, platelet adhesiveness and body weight in human volunteersHemodynamic and cardiac consequences of childhood obesity.The genetics and pathophysiology of type II and gestational diabetes.Insulin resistance in systemic hypertension: pharmacotherapeutic implications.A perspective on the hormonal abnormalities of obesity: are they cause or effect?In vivo insulin action in genetic models of hypertension.Prevalence of the metabolic syndrome across cardiorespiratory fitness levels in women.Metabolic response to oral glucose in healthy South African white, Indian, and African subjects.Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population.Beneficial effects of fish oil on glucose metabolism in spontaneously hypertensive rats.A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.Hyperinsulinemia and dyslipidemia in non-obese, normotensive offspring of hypertensive parents in northern India.Prevalence of undiagnosed non-insulin-dependent diabetes mellitus and impaired glucose tolerance in a cohort of older persons with hypertension.Impaired glucose and insulin metabolism in borderline hypertension.Hyperinsulinemia in hypertension: increased secretion, reduced clearance or both?High blood pressure and hyperinsulinaemia in acromegaly and in obesity.Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study.Glucose tolerance and insulin response in atherosclerosis.Smoking and atherosclerosis.Functional food science and the cardiovascular system.
P2860
Q24561737-D1DE88EE-2DCB-4996-A675-414649EAD19AQ24564030-2C2494EA-205A-4512-AE5E-C4598E79658FQ30420193-000C8EF1-BA61-4A17-9015-BFBE5BB29FB4Q33358112-35902257-4193-4FAE-A7A6-8A6D04DC0766Q33936947-68783B44-95E5-4E1A-8ED1-3D0DA4943EC2Q34011027-DA978998-639D-495E-8BB8-2DAADF766931Q35114660-8DB85854-28D3-4BC8-9E3D-0EF6430B1D42Q35603254-5E99E37F-9C53-4980-8E20-FEDED58CDE81Q35684770-1D3C11EF-C1AE-44BB-B5F9-81A0EAE46593Q35898736-0529DFCF-DF1B-46A1-84DD-D9826E13170EQ36061510-EFDF473C-A968-479E-A241-F6B909B1A179Q36339952-04A15A4B-0940-4AF5-AD0C-9373F4F5151AQ36492706-26DE6836-FDD5-4C00-A1DB-E28FA55C4F98Q36682296-FD10C3C0-1875-44E7-8A8A-13748DE69AA6Q36709546-DDB0DAD1-5BE0-4B04-9261-6EABF52F61F5Q36756593-884AAD70-792F-4B74-8080-CD02EBB9F488Q36902714-CB9F0DB7-B185-48C5-8663-E8B3025F68EFQ37015491-CFF1BEC3-8F26-45F8-B8DB-4D879E852E86Q37421761-D3ECADD5-1BBD-479F-9ABC-AF6B5DF117E8Q40329140-84731DEC-1EFA-4A15-91F3-A2AE6E7917D6Q40793729-BA318F85-91EA-439E-8D23-6B32D0E632B5Q40945389-3A193AAE-CB20-450E-967D-289081740F6AQ40949586-EAD97762-0AC3-41EA-B16B-9126591B419EQ42487962-D8909A38-17DE-471F-818C-2D4B1561A823Q43839565-766CF835-4CD7-4FA8-ABB4-B5295E5C68DCQ47976697-36494426-CC88-4511-95C4-D322A6A1EE88Q49178360-B82E673F-6958-44A4-80AD-8FD129D6D628Q51313505-729B6A98-C2EE-472B-BDA8-DF65C21D950AQ51556050-D3E6F44C-40AF-4229-9FBD-0D7EAD01FF17Q51563223-F9990812-8FAD-4A71-863E-8CCC743AD7AAQ51563661-F9770841-B69C-4B97-958A-F03798FEC593Q51575268-3B6FB5E6-426C-43C6-8FB2-7C5C55374625Q51594002-01F0504A-5571-44B7-9F10-E1FFBA5F7A03Q51600901-2E82B9D8-329E-45E7-BF16-07C4211FC600Q51623079-090F06CB-59BC-4416-9A8C-E5149C6FEBAEQ51660010-16404469-64A0-4B33-8167-5ECF6CDE8DBBQ51683289-B67F901C-E019-4E1E-A47D-C16A3D72DCF1Q51689371-CA93750C-9796-4CA4-8E44-3717C6056B5DQ54113163-8D8B2AE6-5610-4B27-ABCB-FA1832B37E44
P2860
Serum-insulin in essential hypertension and in peripheral vascular disease.
description
1966 nî lūn-bûn
@nan
1966年の論文
@ja
1966年学术文章
@wuu
1966年学术文章
@zh-cn
1966年学术文章
@zh-hans
1966年学术文章
@zh-my
1966年学术文章
@zh-sg
1966年學術文章
@yue
1966年學術文章
@zh
1966年學術文章
@zh-hant
name
Serum-insulin in essential hypertension and in peripheral vascular disease.
@en
Serum-insulin in essential hypertension and in peripheral vascular disease.
@nl
type
label
Serum-insulin in essential hypertension and in peripheral vascular disease.
@en
Serum-insulin in essential hypertension and in peripheral vascular disease.
@nl
prefLabel
Serum-insulin in essential hypertension and in peripheral vascular disease.
@en
Serum-insulin in essential hypertension and in peripheral vascular disease.
@nl
P2093
P1433
P1476
Serum-insulin in essential hypertension and in peripheral vascular disease.
@en
P2093
A Breckenridge
A H Rubinstein
C T Dollery
T A Welborn
T R Fraser
P304
P356
10.1016/S0140-6736(66)92132-5
P407
P577
1966-06-01T00:00:00Z